Hannes Todt

7PUBLICATIONS
14CO-AUTHORS
Electrical energy generation (incl. renewables, excl. photovoltaics)Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Medical biochemistry - lipidsCircuits and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2025
The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels.

Jakob Sauer, Jessica Marksteiner, Martin Hohenegger

|Aug 11, 2025
Inhibition of tenascin C rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes.

Jessica Marksteiner, Jakob Sauer, Martin Hohenegger

|Dec 15, 2023
Empagliflozin treatment rescues abnormally reduced Na+ currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice.

Jakob Sauer, Jessica Marksteiner, Elena Lilliu

|May 23, 2020
Oral batyl alcohol supplementation rescues decreased cardiac conduction in ether phospholipid-deficient mice.

Hannes Todt, Fabian Dorninger, Peter J Rothauer

|May 09, 2020
Reduced Na+ current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy.

Janine Ebner, Pavel Uhrin, Petra L Szabo

Pageof 2